{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:29:25Z","timestamp":1791944965734,"version":"4.3.4"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ijbiomac.2026.152984","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:25:55Z","timestamp":1781076355000},"page":"152984","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Curcumin-based nanomaterials for dual-target inhibition of SARS-CoV-2 omicron main protease and HMPV RNA polymerase: A computational study"],"prefix":"10.1016","volume":"371","author":[{"given":"Maryam","family":"Ebrahimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Dodangeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Javan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Doroudian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mobina","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152984_bb0005","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12985-024-02327-9","article-title":"Epidemiology and diagnosis technologies of human metapneumovirus in China: a mini review","volume":"21","author":"Feng","year":"2024","journal-title":"Virol. J."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.152984_bb0010","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3390\/v12050542","article-title":"Cell-mediated responses to human Metapneumovirus infection","volume":"12","author":"Ballegeer","year":"2020","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152984_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2025.116809","article-title":"Global impact of hMPV virus: transmission, pathogenesis, diagnostic and treatment","volume":"112","author":"Porwal","year":"2025","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152984_bb0020","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jcrc.2015.09.035","article-title":"The role of human metapneumovirus in the critically ill adult patient","volume":"31","author":"Hasvold","year":"2016","journal-title":"J. Crit. Care"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152984_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e13952","article-title":"An update on COVID-19: SARS-CoV-2 variants, antiviral drugs, and vaccines","volume":"9","author":"Hillary","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.ijbiomac.2026.152984_bb0030","series-title":"COVID-19 Epidemiological Update","first-page":"31","author":"W.H.O. (WHO)","year":"2025"},{"key":"10.1016\/j.ijbiomac.2026.152984_bb0035","author":"WHO"},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.152984_bb0040","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1099\/jgv.0.000959","article-title":"ICTV virus taxonomy profile: Pneumoviridae","volume":"98","author":"Rima","year":"2017","journal-title":"J. Gen. Virol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152984_bb0045","doi-asserted-by":"crossref","DOI":"10.1093\/ve\/veaa061","article-title":"Temporal signal and the phylodynamic threshold of SARS-CoV-2","volume":"6","author":"Duchene","year":"2020","journal-title":"Virus Evolution"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152984_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2020.115094","article-title":"Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the coronavirus disease 2019 (COVID-19), a comprehensive literature review","volume":"98","author":"Ortiz-Prado","year":"2020","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2026.152984_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.105709","volume":"147","author":"Ebrahimi","year":"2022","journal-title":"Comput. Biol. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152984_bb0060","doi-asserted-by":"crossref","first-page":"5196","DOI":"10.1038\/s41467-022-32854-4","article-title":"X-ray crystallographic characterization of the SARS-CoV-2 main protease polyprotein cleavage sites essential for viral processing and maturation","volume":"13","author":"Lee","year":"2022","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.152984_bb0065","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s12033-023-00831-x","article-title":"Screening of potential inhibitors targeting the main protease structure of SARS-CoV-2 via molecular docking, and approach with molecular dynamics, RMSD, RMSF, H-Bond, SASA and MMGBSA","volume":"66","author":"da Fonseca","year":"2024","journal-title":"Mol. Biotechnol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.152984_bb0070","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3390\/v14040677","article-title":"Zoonotic origins of human Metapneumovirus: a journey from birds to humans","volume":"14","author":"Jesse","year":"2022","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152984_bb0075","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-023-04990-0","article-title":"Conserved allosteric inhibitory site on the respiratory syncytial virus and human metapneumovirus RNA-dependent RNA polymerases","volume":"6","author":"Kleiner","year":"2023","journal-title":"Commun. Biol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.152984_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/v14102200","article-title":"Revisiting viral RNA-dependent RNA polymerases: insights from recent structural studies","volume":"14","author":"Ramaswamy","year":"2022","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.152984_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/v13050834","article-title":"Structural insights into the respiratory syncytial virus RNA synthesis complexes","volume":"13","author":"Cao","year":"2021","journal-title":"Viruses"},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.152984_bb0090","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1128\/AAC.47.12.3907-3916.2003","article-title":"Phase II, randomized, double-blind, placebo-controlled studies of Ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers","volume":"47","author":"Hayden","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152984_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005531","article-title":"Reversal of the progression of fatal coronavirus infection in cats by a broad-Spectrum coronavirus protease inhibitor","volume":"12","author":"Kim","year":"2016","journal-title":"PLoS Pathog."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.152984_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0030324","article-title":"Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases","volume":"3","author":"Yang","year":"2005","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ijbiomac.2026.152984_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131756","article-title":"RdRp (RNA-dependent RNA polymerase): a key target providing anti-virals for the management of various viral diseases","volume":"1250","author":"Pathania","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ijbiomac.2026.152984_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.104748","article-title":"Computational repurposing of tamibarotene against triple mutant variant of SARS-CoV-2","volume":"136","author":"Mujwar","year":"2021","journal-title":"Comput. Biol. Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152984_bb0115","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01243-24","article-title":"The role of M2 proteins of pneumoviruses in transcription regulation, prevention of hypermutation, and activation of the type I interferon pathway","volume":"99","author":"Rib\u00f3-Molina","year":"2025","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152984_bb0120","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev-virology-101416-041718","article-title":"Mechanisms and concepts in RNA virus population dynamics and evolution","volume":"5","author":"Dolan","year":"2018","journal-title":"Annu Rev Virol"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.152984_bb0125","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.3390\/v14051058","article-title":"Global extension and predominance of human metapneumovirus A2 genotype with partial G gene duplication","volume":"14","author":"Mu\u00f1oz-Escalante","year":"2022","journal-title":"Viruses"},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.152984_bb0130","article-title":"From alpha to omicron: how different variants of concern of the SARS-Coronavirus-2 impacted the world","volume":"12","author":"Andre","year":"2023","journal-title":"Biol.-Basel"},{"key":"10.1016\/j.ijbiomac.2026.152984_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115772","article-title":"Structure and function of SARS-CoV and SARS-CoV-2 main proteases and their inhibition: a comprehensive review","volume":"260","author":"Li","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"Pt 12","key":"10.1016\/j.ijbiomac.2026.152984_bb0140","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1099\/vir.0.83250-0","article-title":"Enhanced lung disease and Th2 response following human metapneumovirus infection in mice immunized with the inactivated virus","volume":"88","author":"Hamelin","year":"2007","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.ijbiomac.2026.152984_bb0145","author":"W.H.O. (WHO)"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152984_bb0150","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-95025-3","article-title":"Rates of SARS-CoV-2 transmission and vaccination impact the fate of vaccine-resistant strains","volume":"11","author":"Rella","year":"2021","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.152984_bb0155","doi-asserted-by":"crossref","DOI":"10.1007\/s12247-025-10194-2","article-title":"In silico discovery of Tanshinone I, a diterpenoid from *Salvia miltiorrhiza* (Danshen), as a dual antiviral natural inhibitor targeting conserved allosteric sites of HMPV and HRSV RNA-dependent RNA polymerases","volume":"20","author":"Debnath","year":"2025","journal-title":"J. Pharm. Innov."},{"key":"10.1016\/j.ijbiomac.2026.152984_bb0160","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijid.2014.03.1394","article-title":"Human metapneumovirus: review of an important respiratory pathogen","volume":"25","author":"Panda","year":"2014","journal-title":"Int. J. Infect. Dis."},{"issue":"43","key":"10.1016\/j.ijbiomac.2026.152984_bb0165","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v20.i43.16184","article-title":"Ribavirin induced hemolysis: a novel mechanism of action against chronic hepatitis C virus infection","volume":"20","author":"Soota","year":"2014","journal-title":"World J Gastroenterol: WJG"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152984_bb0170","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cll.2009.10.002","article-title":"Human metapneumovirus","volume":"30","author":"Hermos","year":"2010","journal-title":"Clin. Lab. Med."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.152984_bb0175","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1128\/CVI.00230-15","article-title":"New approaches for immunization and therapy against human Metapneumovirus","volume":"22","author":"Wen","year":"2015","journal-title":"Clin. Vaccine Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152984_bb0180","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.antiviral.2004.02.006","article-title":"Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by NMSO3 in tissue culture assays","volume":"63","author":"Wyde","year":"2004","journal-title":"Antivir. Res."},{"issue":"16","key":"10.1016\/j.ijbiomac.2026.152984_bb0185","doi-asserted-by":"crossref","first-page":"7799","DOI":"10.1128\/JVI.00318-06","article-title":"Isolation and characterization of monoclonal antibodies which neutralize human metapneumovirus in vitro and in vivo","volume":"80","author":"Nancy","year":"2006","journal-title":"Journal of Virology"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152984_bb0190","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/infdis\/jiu307","article-title":"A broadly neutralizing human monoclonal antibody exhibits in vivo efficacy against both human Metapneumovirus and respiratory syncytial virus","volume":"211","author":"Schuster","year":"2014","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.152984_bb0195","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3390\/vaccines13050465","article-title":"COVID-19 vaccination in patients with hematological malignances","volume":"13","author":"Franchini","year":"2025","journal-title":"Vaccines"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152984_bb0200","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"issue":"19","key":"10.1016\/j.ijbiomac.2026.152984_bb0205","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19 \u2014 final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2026.152984_bb0210","article-title":"The development of COVID-19 treatment","volume":"14\u20132023","author":"Yuan","year":"2023","journal-title":"Front. Immunol."},{"issue":"10289","key":"10.1016\/j.ijbiomac.2026.152984_bb0215","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/S0140-6736(21)00897-7","volume":"397","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ijbiomac.2026.152984_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114367","article-title":"Paxlovid (Nirmatrelvir\/ritonavir): a new approach to Covid-19 therapy?","volume":"162","author":"Hashemian","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2026.152984_bb0225","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.antiviral.2018.03.003","article-title":"Favipiravir as a potential countermeasure against neglected and emerging RNA viruses","volume":"153","author":"Delang","year":"2018","journal-title":"Antivir. Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152984_bb0230","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.antiviral.2013.09.015","article-title":"Favipiravir (T-705), a novel viral RNA polymerase inhibitor","volume":"100","author":"Furuta","year":"2013","journal-title":"Antivir. Res."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.152984_bb0235","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa2031994","article-title":"Baricitinib plus Remdesivir for hospitalized adults with Covid-19","volume":"384","author":"Kalil","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.152984_bb0240","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/jmv.25731","article-title":"Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2","volume":"92","author":"Li","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.ijbiomac.2026.152984_bb0245","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijid.2020.11.142","article-title":"Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: a randomized, comparative, open-label, multicenter, phase 3 clinical trial","volume":"103","author":"Udwadia","year":"2021","journal-title":"Int. J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152984_bb0250","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1080\/07853890.2022.2031274","article-title":"Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines","volume":"54","author":"Fernandes","year":"2022","journal-title":"Ann. Med."},{"key":"10.1016\/j.ijbiomac.2026.152984_bb0255","series-title":"Phase 3 Trial Shows REGEN-COV\u2122 (Casirivimab with Imdevimab) Antibody Cocktail Reduced Hospitalization or Death by 70% in Non-hospitalized COVID-19 Patients","author":"Tarrytown","year":"2021"},{"issue":"2_suppl","key":"10.1016\/j.ijbiomac.2026.152984_bb0260","doi-asserted-by":"crossref","DOI":"10.4081\/jphr.2021.2930","article-title":"REGEN-COV and COVID-19, update on the drug profile and FDA status: a mini-review and bibliometric study","volume":"10","author":"Mawazi","year":"2021","journal-title":"J. Public Health Res."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.152984_bb0265","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jmii.2020.05.014","article-title":"Lopinavir\/ritonavir use in Covid-19 infection: is it completely non-beneficial?","volume":"53","author":"Owa","year":"2020","journal-title":"J. Microbiol. Immunol. Infect."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.152984_bb0270","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cmi.2020.05.006","article-title":"Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19","volume":"26","author":"Gevers","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"issue":"19","key":"10.1016\/j.ijbiomac.2026.152984_bb0275","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1056\/NEJMoa2015301","article-title":"Remdesivir for 5 or 10 days in patients with severe Covid-19","volume":"383","author":"Goldman","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.152984_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105938","article-title":"New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?","volume":"55","author":"Devaux","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"46","key":"10.1016\/j.ijbiomac.2026.152984_bb0285","doi-asserted-by":"crossref","first-page":"42964","DOI":"10.1021\/acsami.9b15032","article-title":"Functional carbon quantum dots as medical countermeasures to human coronavirus","volume":"11","author":"\u0141oczechin","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"42","key":"10.1016\/j.ijbiomac.2026.152984_bb0290","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2304139120","article-title":"2-thiouridine is a broad-spectrum antiviral nucleoside analogue against positive-strand RNA viruses","volume":"120","author":"Uemura","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.152984_bb0295","doi-asserted-by":"crossref","first-page":"5897","DOI":"10.1021\/acsabm.1c00523","article-title":"Antiviral properties of alginate-based biomaterials: promising antiviral agents against SARS-CoV-2","volume":"4","author":"Serrano-Aroca","year":"2021","journal-title":"ACS Appl. Bio Mater."},{"issue":"16","key":"10.1016\/j.ijbiomac.2026.152984_bb0300","doi-asserted-by":"crossref","first-page":"4392","DOI":"10.1039\/D2BM00472K","article-title":"Antimicrobial mechanisms of biomaterials: from macro to nano","volume":"10","author":"Roy","year":"2022","journal-title":"Biomater. Sci."},{"issue":"18","key":"10.1016\/j.ijbiomac.2026.152984_bb0305","doi-asserted-by":"crossref","first-page":"20652","DOI":"10.1021\/acsami.2c01385","article-title":"Double-edged Nanobiotic platform with protean functionality: leveraging the synergistic antibacterial activity of a food-grade peptide to mitigate multidrug-resistant bacterial pathogens","volume":"14","author":"Kumar","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.152984_bb0310","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/bph.12009","article-title":"Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea","volume":"168","author":"Steinmann","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152984_bb0315","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-98243-x","article-title":"Curcumin inhibited hepatitis B viral entry through NTCP binding","volume":"11","author":"Thongsri","year":"2021","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152984_bb0320","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3390\/compounds2030017","article-title":"Ethnomedicinal, phytochemistry and antiviral potential of turmeric (Curcuma longa)","volume":"2","author":"Srivastava","year":"2022","journal-title":"Compounds"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152984_bb0325","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1038\/s41598-021-81462-7","article-title":"Catechin and curcumin interact with S protein of SARS-CoV2 and ACE2 of human cell membrane: insights from computational studies","volume":"11","author":"Jena","year":"2021","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.152984_bb0330","article-title":"Understanding the role of natural medicinal compounds such as curcumin and allicin against SARS-CoV-2 proteins as potential treatment against COVID-19: an in silico approach","volume":"13","author":"Bastikar","year":"2020","journal-title":"Proteome Sci. Bioinform."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152984_bb0335","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s43141-023-00548-z","article-title":"Porphyrin-derived carbon dots for an enhanced antiviral activity targeting the CTD of SARS-CoV-2 nucleocapsid","volume":"21","author":"Fibriani","year":"2023","journal-title":"J. Genet. Eng. Biotechnol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.152984_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e20089","article-title":"Curcumin-derived carbon-dots as a potential COVID-19 antiviral drug","volume":"9","author":"Fibriani","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.ijbiomac.2026.152984_bb0345","article-title":"Antiviral properties of select carbon nanostructures and their functionalized analogs","volume":"29","author":"Gupta","year":"2021","journal-title":"Mater. Today Commun."},{"key":"10.1016\/j.ijbiomac.2026.152984_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2021.116942","article-title":"Molecular docking, DFT analysis, and dynamics simulation of natural bioactive compounds targeting ACE2 and TMPRSS2 dual binding sites of spike protein of SARS CoV-2","volume":"342","author":"Yadav","year":"2021","journal-title":"J. Mol. Liq."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.152984_bb0355","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2298\/JSC220921087K","article-title":"Curcumin as a potential multiple-target inhibitor against SARS-CoV-2 infection: a detailed interaction study using quantum chemical calculations","volume":"88","author":"Kumar","year":"2023","journal-title":"J. Serb. Chem. Soc."},{"key":"10.1016\/j.ijbiomac.2026.152984_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.105552","article-title":"Curcumin inhibits spike protein of new SARS-CoV-2 variant of concern (VOC) omicron, an in silico study","volume":"146","author":"Nag","year":"2022","journal-title":"Comput. Biol. Med."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.152984_bb0365","doi-asserted-by":"crossref","first-page":"5138","DOI":"10.1080\/07391102.2020.1868338","article-title":"Virtual screening of curcumin and its analogs against the spike surface glycoprotein of SARS-CoV-2 and SARS-CoV","volume":"40","author":"Patel","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"41","key":"10.1016\/j.ijbiomac.2026.152984_bb0370","article-title":"High amplification of the antiviral activity of curcumin through transformation into carbon quantum dots","volume":"15","author":"Lin","year":"2019","journal-title":"Small"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.152984_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101957","article-title":"Development of antiviral carbon quantum dots that target the Japanese encephalitis virus envelope protein","volume":"298","author":"Chen","year":"2022","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.152984_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiph.2025.102885","article-title":"Unlocking antiviral potentials of traditional plants: A multi-method computational study against human metapneumovirus (HMPV)","volume":"18","author":"Dubey","year":"2025","journal-title":"J. Infect. Public Health"},{"key":"10.1016\/j.ijbiomac.2026.152984_bb0385","series-title":"Structure of SARS-CoV-2 Mpro Omicron P132H in complex with Nirmatrelvir (PF-07321332), Protein Data Bank (PDB)","author":"Greasley","year":"2022"},{"key":"10.1016\/j.ijbiomac.2026.152984_bb0390","series-title":"Structure of the Human Metapneumovirus Polymerase Bound to the Phosphoprotein Tetramer, Protein Data Bank (PDB)","author":"Pan","year":"2019"},{"key":"10.1016\/j.ijbiomac.2026.152984_bb0395","unstructured":"RCSB Protein Data Bank https:\/\/www.rcsb.org\/. (Accessed 9 June, 2025)."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.152984_bb0400","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"issue":"22","key":"10.1016\/j.ijbiomac.2026.152984_bb0405","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1016\/0040-4020(80)80168-2","article-title":"Iterative partial equalization of orbital electronegativity\u2014a rapid access to atomic charges","volume":"36","author":"Gasteiger","year":"1980","journal-title":"Tetrahedron"},{"issue":"13","key":"10.1016\/j.ijbiomac.2026.152984_bb0410","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.152984_bb0415","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/wics.117","article-title":"Steepest descent","volume":"2","author":"Meza","year":"2010","journal-title":"Wiley Interdisciplinary Reviews: Computational Statistics"},{"key":"10.1016\/j.ijbiomac.2026.152984_bb0420","series-title":"An Introduction to the Conjugate Gradient Method without the Agonizing Pain","author":"Shewchuk","year":"1994"},{"key":"10.1016\/j.ijbiomac.2026.152984_bb0425","author":"N.C.F.B. Information"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152984_bb0430","first-page":"17","article-title":"Avogadro: an advanced semantic chemical editor, visualization, and analysis platform","volume":"4","author":"Hanwell","year":"2012","journal-title":"J. Chem."},{"issue":"14","key":"10.1016\/j.ijbiomac.2026.152984_bb0435","doi-asserted-by":"crossref","first-page":"16701","DOI":"10.1021\/acsomega.4c00759","article-title":"Theoretical investigation of the green-synthesized carbon-based nanomaterial potential as inhibitors of ACE2 for blocking SARS-CoV-2 binding","volume":"9","author":"Sari","year":"2024","journal-title":"ACS Omega"},{"issue":"W1","key":"10.1016\/j.ijbiomac.2026.152984_bb0440","doi-asserted-by":"crossref","first-page":"W422","DOI":"10.1093\/nar\/gkae236","article-title":"ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support","volume":"52","author":"Fu","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.152984_bb0445","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1021\/jm901137j","article-title":"New substructure filters for removal of Pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays","volume":"53","author":"Baell","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2026.152984_bb0450","series-title":"Gaussian 09, Revision d. 01, Gaussian, Inc, Wallingford CT 201","author":"Frisch","year":"2009"},{"key":"10.1016\/j.ijbiomac.2026.152984_bb0455","series-title":"GaussView, Version 5, Semichem Inc., Shawnee Mission, KS","author":"Dennington","year":"2009"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.152984_bb0460","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/jcc.22885","article-title":"Multiwfn: a multifunctional wavefunction analyzer","volume":"33","author":"Lu","year":"2012","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ijbiomac.2026.152984_bb0465","series-title":"Gnuplot 4.4: an interactive plotting program","author":"Williams","year":"2010"},{"key":"10.1016\/j.ijbiomac.2026.152984_bb0470","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD - visual molecular dynamics","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"10.1016\/j.ijbiomac.2026.152984_bb0475","series-title":"IrfanView","author":"Skiljan","year":"2004"},{"issue":"18","key":"10.1016\/j.ijbiomac.2026.152984_bb0480","doi-asserted-by":"crossref","first-page":"6498","DOI":"10.1021\/ja100936w","article-title":"Revealing noncovalent interactions","volume":"132","author":"Johnson","year":"2010","journal-title":"J. Am. Chem. Soc."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152984_bb0485","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"W1","key":"10.1016\/j.ijbiomac.2026.152984_bb0490","doi-asserted-by":"crossref","first-page":"W159","DOI":"10.1093\/nar\/gkac394","article-title":"CB-Dock2: improved protein\u2013ligand blind docking by integrating cavity detection, docking and homologous template fitting","volume":"50","author":"Liu","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.152984_bb0495","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1021\/ja026939x","article-title":"HADDOCK: a protein\u2212 protein docking approach based on biochemical or biophysical information","volume":"125","author":"Dominguez","year":"2003","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijbiomac.2026.152984_bb0500","series-title":"Discovery Studio Visualizer Software, Version 4.0","author":"Biovia","year":"2012"},{"key":"10.1016\/j.ijbiomac.2026.152984_bb0505","series-title":"GROMACS User Manual","author":"Lindahl","year":"2012"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.152984_bb0510","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1021\/ja00214a001","article-title":"The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin","volume":"110","author":"Jorgensen","year":"1988","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152984_bb0515","doi-asserted-by":"crossref","DOI":"10.1063\/1.2408420","article-title":"Canonical sampling through velocity rescaling","volume":"126","author":"Bussi","year":"2007","journal-title":"J. Chem. Phys."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.152984_bb0520","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1063\/1.328693","article-title":"Polymorphic transitions in single crystals: a new molecular dynamics method","volume":"52","author":"Parrinello","year":"1981","journal-title":"J. Appl. Phys."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.152984_bb0525","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1063\/1.458517","article-title":"A simple measure of electron localization in atomic and molecular systems","volume":"92","author":"Becke","year":"1990","journal-title":"J. Chem. Phys."},{"issue":"6499","key":"10.1016\/j.ijbiomac.2026.152984_bb0530","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/371683a0","article-title":"Classification of chemical bonds based on topological analysis of electron localization functions","volume":"371","author":"Silvi","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2026.152984_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.insi.2025.100031","article-title":"Structure-based pharmacophore modeling, molecular docking and ADMET analysis to discover potential hMPV inhibitors","volume":"1","author":"Rampogu","year":"2025","journal-title":"In Silico Research in Biomedicine"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152984_bb0540","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3390\/v14020338","article-title":"Detailed analyses of molecular interactions between Favipiravir and RNA viruses in silico","volume":"14","author":"Shirai","year":"2022","journal-title":"Viruses"},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.152984_bb0545","doi-asserted-by":"crossref","first-page":"8933","DOI":"10.1080\/10406638.2022.2157026","article-title":"Design, spectroscopic, and crystal structural characterization of new Pyrazolone-based Schiff bases: molecular docking investigations against SARS-Covid-19 Main proteases (PDB ids: 6LU7 and 7TLL)","volume":"43","author":"Hasanzadeh Esfahani","year":"2023","journal-title":"Polycycl. Aromat. Compd."},{"key":"10.1016\/j.ijbiomac.2026.152984_bb0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.indcrop.2024.119905","article-title":"Comprehensive in silico and in vitro evaluation of Plectranthus amboinicus essential oil: a promising inhibitor of SARS-CoV-2 B.1.1.529 omicron variant, proinflammatory biomarkers and diabetes-related enzymes","volume":"222","author":"Bonalos","year":"2024","journal-title":"Ind. Crop. Prod."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.152984_bb0555","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s13530-024-00238-4","article-title":"Mercury-mediated neurological diseases: insight into molecular mechanisms, mutant proteins, and structure-based therapeutic inhibitors","volume":"16","author":"Zahed","year":"2024","journal-title":"Toxicol. Environ. Heal. Sci."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026029119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026029119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:28:56Z","timestamp":1786724936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026029119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":111,"alternative-id":["S0141813026029119"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.152984","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Curcumin-based nanomaterials for dual-target inhibition of SARS-CoV-2 omicron main protease and HMPV RNA polymerase: A computational study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.152984","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152984"}}